Pasar al contenido principal

IDENTIFICACION Y CARACTERIZACION DE ESTRATEGIAS PARA MODULAR LA ACTIVIDAD DE LOS FIBROBLASTOS ASOCIADOS A CANCER PARA ENTORPECER EL DESARROLLO TUMORAL

RTI2018-096778-A-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance

  • Coursier, Diana
  • Calvo, Fernando
Neoplastic progression involves complex interactions between cancer cells and the surrounding stromal milieu, fostering microenvironments that crucially drive tumor progression and dissemination. Of these stromal constituents, cancer-associated fibroblasts (CAFs) emerge as predominant inhabitants within the tumor microenvironment (TME), actively shaping multiple facets of tumorigenesis, including cancer cell proliferation, invasiveness, and immune evasion. Notably, CAFs also orchestrate the production of pro-angiogenic factors, fueling neovascularization to sustain the metabolic demands of proliferating cancer cells. Moreover, CAFs may also directly or indirectly affect endothelial cell behavior and vascular architecture, which may impact in tumor progression and responses to anti-cancer interventions. Conversely, tumor endothelial cells (TECs) exhibit a corrupted state that has been shown to affect cancer cell growth and inflammation. Both CAFs and TECs are emerging as pivotal regulators of the TME, engaging in multifaceted biological processes that significantly impact cancer progression, dissemination, and therapeutic responses. Yet, the intricate interplay between these stromal components and the orchestrated functions of each cell type remains incompletely elucidated. In this review, we summarize the current understanding of the dynamic interrelationships between CAFs and TECs, discussing the challenges and prospects for leveraging their interactions towards therapeutic advancements in cancer., Spanish Government MCIN/AEI/10.13039/501100011033 (grants RYC-2016‐20352, RTI2018‐096778‐A‐I00, PID2021‐128107OB‐I00); Asociación Española Contra el Cáncer-AECC (grants LABAE19044CALV, PRYCO211372RODR); BBVA Leonardo Awards (grant IN [19]_BBM_BAS_0076), Cancer Research UK (grant C57744/A22057); and the European Research Council-ERC Consolidator Grant antiCAFing (grant ref 101045756). Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed